glp 1 makes me hungry One of the biggest misconceptions I hear about GLP-1 medications is: “I don't feel anymore, so it must be working.” Or… “I'm starting to feel hungry again, so it must have Still feeling hungry while taking

Unfortunately, GLP-1 can decrease with age and lifestyle

Manipulating glutathione-related pathways may offer novel options for preventing the occurrence and development of diabetes

Figure 2: Novel Incretin Mimetic Assets for T2DM and Obesity in Phase 2/3 of Development Remaining Unmet Needs Remaining Unmet Needs Though the value proposition of on-market GLP-1 and dual-agonists is strong, several key unmet needs still exist for incretin mimetics across diabetes and obesity, namely: (1) improved efficacy, (2) better tolerability, (3) more convenient options / alternative ROAs, and (4) improved access and affordability

Anti-Aging: Glutathione IV therapy is often touted for its potential anti-aging effects